Location: New York, NY
CIK: 0001633313 · Show all filings
Period: Q2 2021 (← Previous) (Next →)
Filing Date: Aug 16, 2021
Total Value: $5.748B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | HORIZON THERAPEUTICS PLC | 9,000,000 | $843M | 14.7% | $46.60 | — | Common | G46188101 |
| — | MIRATI THERAPEUTICS INC | 5,000,000 | $808M | 14.0% | $50.41 | — | Common | 60468T105 |
| UTHR | UNITED THERAPEUTICS CORP | 3,000,000 | $538M | 9.4% | $133.00 | +43.2% | Common | 91307C102 |
| — | ACCELERON PHARMA INC | 3,000,000 | $376M | 6.5% | $117.18 | — | Common | 00434H108 |
| ARGX | ARGENX SE | 946,500 | $285M | 5.0% | $77.97 | — | Sponsored ADR | 04016X101 |
| — | ARENA PHARMACEUTICALS INC | 4,075,000 | $278M | 4.8% | $72.64 | — | Common | 040047607 |
| ASND | ASCENDIS PHARMA | 1,900,000 | $250M | 4.3% | $131.55 | — | Sponsored ADR | 04351P101 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 9,100,000 | $237M | 4.1% | $16.37 | +58.8% | Common | 462260100 |
| SRPT | SAREPTA THERAPEUTICS INC | 2,400,000 | $187M | 3.2% | $103.66 | -26.9% | Common | 803607100 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 1,000,000 | $170M | 2.9% | $146.46 | 0.0% | Common | 02043Q107 |
| VRTX | VERTEX PHARMACEUTICALS INC | 790,000 | $159M | 2.8% | $219.65 | -4.8% | Common | 92532F100 |
| MDGL | MADRIGAL PHARMACEUTICALS INC | 1,425,000 | $139M | 2.4% | $124.06 | -4.6% | Common | 558868105 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,650,000 | $138M | 2.4% | $84.64 | -6.3% | Common | 09061G101 |
| FOLD | AMICUS THERAPEUTICS INC | 12,450,000 | $120M | 2.1% | $11.75 | -17.0% | Common | 03152W109 |
| — | CONSTELLATION PHARMACEUTICALS INC | 3,210,000 | $108M | 1.9% | $43.16 | — | Common | 210373106 |
| — | MERSANA THERAPEUTICS INC | 6,800,000 | $92.34M | 1.6% | $23.19 | — | Common | 59045L106 |
| KURA | KURA ONCOLOGY INC | 4,140,000 | $86.32M | 1.5% | $25.17 | -1.4% | Common | 50127T109 |
| XENE | XENON PHARMACEUTICALS INC | 3,650,000 | $67.96M | 1.2% | $11.32 | +62.8% | Common | 98420N105 |
| APLS | APELLIS PHARMACEUTICALS INC | 1,005,230 | $63.53M | 1.1% | $47.32 | +9.1% | Common | 03753U106 |
| PMVP | PMV PHARMACEUTICALS INC | 1,825,000 | $62.34M | 1.1% | $37.32 | -10.5% | Common | 69353Y103 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 3,311,434 | $62.15M | 1.1% | $20.37 | 0.0% | Common | 61225M102 |
| ACAD | ACADIA PHARMACEUTICALS INC | 2,441,658 | $59.55M | 1.0% | $48.41 | -53.4% | Common | 004225108 |
| — | MARINUS PHARMACEUTICALS INC | 3,235,000 | $58.04M | 1.0% | $12.20 | — | Common | 56854Q200 |
| — | TRILLIUM THERAPEUTICS INC | 5,700,000 | $55.29M | 1.0% | $5.91 | — | Common | 89620X506 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3,000,000 | $51.51M | 0.9% | $21.60 | -15.2% | Common | 87164F105 |
| MNKD | MANNKIND CORP | 8,630,000 | $47.03M | 0.8% | $3.53 | +22.6% | Common | 56400P706 |
| — | CYMABAY THERAPEUTICS INC | 10,300,000 | $44.91M | 0.8% | $6.26 | — | Common | 23257D103 |
| — | IVERIC BIO INC | 6,425,000 | $40.54M | 0.7% | $5.11 | — | Common | 46583P102 |
| — | DECIPHERA PHARMACEUTICALS INC | 1,068,000 | $39.1M | 0.7% | $44.83 | — | Common | 24344T101 |
| RLMD | RELMADA THERAPEUTICS INC | 935,000 | $29.93M | 0.5% | $40.49 | -14.2% | Common | 75955J402 |
| — | AVADEL PHARMACEUTICALS PLC | 4,365,000 | $29.38M | 0.5% | $7.90 | — | Sponsored ADR | 05337M104 |
| — | PRAXIS PRECISION MEDICINES INC | 1,600,000 | $29.25M | 0.5% | $43.99 | — | Common | 74006W108 |
| DSGN | DESIGN THERAPEUTICS INC | 1,468,318 | $26.41M | 0.5% | $31.14 | -19.0% | Common | 25056L103 |
| — | AMARIN CORP PLC | 6,000,000 | $26.28M | 0.5% | $8.22 | — | Sponsored ADR | 023111206 |
| OLMA | OLEMA PHARMACEUTICALS INC | 876,986 | $24.54M | 0.4% | $46.89 | -39.3% | Common | 68062P106 |
| — | ADVERUM BIOTECHNOLOGIES INC | 6,950,000 | $24.32M | 0.4% | $11.14 | — | Common | 00773U108 |
| — | MERUS N V | 660,000 | $13.91M | 0.2% | $20.89 | — | Common | N5749R100 |
| RNAM | AVIDITY BIOSCIENCES INC | 545,000 | $13.47M | 0.2% | $28.83 | -19.3% | Common | 05370A108 |
| FENC | FENNEC PHARMACEUTICALS INC | 1,670,000 | $12.17M | 0.2% | $9.85 | -32.3% | Common | 31447P100 |
| GNCAQ | GENOCEA BIOSCIENCES INC | 5,084,184 | $11.9M | 0.2% | $2.62 | -8.1% | Common | 372427401 |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 500,000 | $11.11M | 0.2% | $22.21 | — | Sponsored ADS | 152309100 |
| — | BCTG ACQUISITION CORP | 800,000 | $9.096M | 0.2% | $10.84 | — | Common | 05492W103 |
| ADAPY | ADAPTIMMUNE THERAPEUTICS PLC | 2,024,400 | $8.624M | 0.2% | $9.83 | — | Sponsored ADR | 00653A107 |
| — | AERPIO PHARMACEUTICALS INC | 4,500,000 | $7.605M | 0.1% | $1.69 | — | Common | 00810B105 |
| APLS | APELLIS PHARMACEUTICALS INC | 240,000 | $3.36M | 0.1% | $47.32 | +9.1% | Call | 03753U106 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 150,000 | $1.425M | 0.0% | $146.46 | 0.0% | Call | 02043Q107 |